The topic was discussed during a lecture at the 43rd CIOSP, the largest dentistry congress in Latin America, focusing on scientific evidence and the impacts of Anvisa's new regulation on dental practice in the treatment of orofacial pain

The topic was discussed during a lecture at the 43rd CIOSP, the largest dentistry congress in Latin America, focusing on scientific evidence and the impacts of Anvisa's new regulations on dental practice in the treatment of orofacial pain.

Based on evidence and a humanized approach, integrative dentists envision an active role in the medicinal cannabis market

CFO supports dentists among authorized professionals to prescribe safely and with quality

Lecture led by specialist will address scientific updates, clinical use, and regulation of cannabinoid therapies in Dentistry during the event in São Paulo

Explore the scientific foundations and clinical practices that support the use of cannabis in dental treatment

Event gathers professionals and experts in Goiânia to discuss the regulatory framework and therapeutic applications of Medical Cannabis

Resolution No. 365 of the Federal Council of Biomedicine, which authorizes the prescription of traditional herbal products based on cannabidiol by biomedical professionals, clashes with resolutions of the health agency

Despite difficulties, a survey shows that in the first seven months of 2022, judicial authorizations for the cultivation and use of cannabis compounds for medicinal purposes were higher compared to the same period the previous year

The Federal Bill that authorizes and sets regulations for cultivation and other issues, PL399/2015, is still pending. Some municipalities have already implemented their initiatives on the subject since 2021. Now, with the law sanctioned in the state of São Paulo and

Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs

CFF will appeal the court decision that suspended Resolution No. 586/2013

Caroline Campagnone views RDC 999/2025 favorably, allowing veterinarians authorized by CFMV to prescribe medical cannabis

Brazilian delegation led by Abiquifi participates in a mission to Colombia to exchange experiences on the regulation of cannabis cultivation, with representatives from MAPA, Anvisa, Embrapa, and major pharmaceutical industries

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

Anvisa's update "mirrors" the rules for controlling cannabis products directly in the list of controlled substances and defines classification for industrial inputs

Return strengthens Brazil's role in shaping global chemistry standards and boosts initiatives related to the cannabis production chain in the country

Understand the step-by-step process to acquire plant derivatives for medicinal purposes

Brazilian delegation visits pharmaceutical facilities in Colombia and participates in over 40 business meetings to strengthen partnerships and advance discussions on the regulation of cannabis cultivation

João Carlos Normanha criticizes the absence of the topic in undergraduate programs and advocates for comprehensive training of professionals from the beginning of their careers